Effect of Probiotic Soy Milk on Serum Levels of Adiponectin, Inflammatory Mediators, Lipid Profile, and Fasting Blood Glucose Among Patients with Type II Diabetes Mellitus

Probiotics and Antimicrobial Proteins

Volumn 9, Issue 1, 2017, Pages 41-47

  Feizollahzadeh, Sadegh ^a   Ghiasvand, Reza ^b   Rezaei, Abbas ^a   Khanahmad, Hossein ^a   sadeghi, Akram ^a   Hariri, Mitra ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NEYSHABUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Inflammation; Lipid profile; Probiotics; Type 2 diabetes

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; LIPID;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; LACTOBACILLUS PLANTARUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN MILK; BLOOD; DIET RESTRICTION; DIET THERAPY; LACTOBACILLUS ACIDOPHILUS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ADULT; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; HUMANS; LACTOBACILLUS ACIDOPHILUS; LIPIDS; MALE; MIDDLE AGED; PROBIOTICS; SOY MILK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84991579823     PISSN: 18671306     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12602-016-9233-y     Document Type: Article

References (38)

1. Stumvoll M, Goldstein BJ, van Haeften TW (2005) Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365:1333–1346
2. Relimpio F (2003) “The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes”, by Kahn SE. Diabetologia 46:1707
3. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17:4–12
4. Lihn AS, Pedersen SB, Richelsen B (2005) Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13–21
5. Moller DE (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11:212–217
6. Borst SE (2004) The role of TNF-alpha in insulin resistance. Endocrine 23:177–182
7. Lin X, Zhang Z, Chen JM, Xu YY, Ye HR, Cui J et al (2015) Role of APN and TNF-alpha in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease. Genet Mol Res 14:2940–2946
8. Larter CZ, Farrell GC (2006) Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat? J Hepatol 44:253–261
9. Ouchi N, Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta Int J Clin Chem 380:24–30
10. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J (2004) Beyond insulin resistance in NASH: tNF-alpha or adiponectin? Hepatology 40:46–54
11. Lye HS, Kuan CY, Ewe JA, Fung WY, Liong MT (2009) The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens. Int J Mol Sci 10:3755–3775
12. Panwar H, Rashmi HM, Batish VK, Grover S (2013) Probiotics as potential biotherapeutics in the management of type 2 diabetes—prospects and perspectives. Diabetes Metab Res Rev 29:103–112
13. Goldin BR (1998) Health benefits of probiotics. Br J Nutr 80(4):S203–S207
14. Boirivant M, Strober W (2007) The mechanism of action of probiotics. Curr Opin Gastroenterol 23:679–692
15. Sanders ME (2003) Probiotics: considerations for human health. Nutr Rev 61(3):91–99
16. Corthesy B, Gaskins HR, Mercenier A (2007) Cross-talk between probiotic bacteria and the host immune system. J Nutr 137:781s–790s
17. Isolauri E, Sutas Y, Kankaanpaa P, Arvilommi H, Salminen S (2001) Probiotics: effects on immunity. Am J Clin Nutr 73:444s–450s
18. Hariri M, Salehi R, Feizi A, Mirlohi M, Kamali S, Ghiasvand R (2015) The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: a randomized double-blind clinical trial. ARYA Atheroscler 11:74–80
19. Olveira G, Gonzalez-Molero I (2016) An update on probiotics, prebiotics and symbiotics in clinical nutrition. Endocrinol Nutr. doi:10.1016/j.endonu.2016.07.006
20. Samah S, Ramasamy K, Lim SM, Neoh CF (2016) Probiotics for the management of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 118:172–182
21. Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M (2014) Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci 17:815–819
22. Bahls LD, Venturini D, Scripes Nde A, Lozovoy MA, Simao TN, Simao AN et al (2011) Evaluation of the intake of a low daily amount of soybeans in oxidative stress, lipid and inflammatory profile, and insulin resistance in patients with metabolic syndrome. Arq Bras Endocrinol Metabol 55:399–405
23. Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K (2008) Increased insulin sensitivity and changes in the expression profile of key insulin regulatory genes and beta cell transcription factors in diabetic KKAy-mice after feeding with a soy bean protein rich diet high in isoflavone content. J Agric Food Chem 56:4377–4385
24. Ristic Medic D, Ristic V, Arsic A, Postic M, Ristic G, Blazencic Mladenovic V et al (2006) Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Nutr Metab Cardiovasc Dis NMCD 16:395–404
25. Zielinska D, Kolozyn-Krajewska D, Goryl A, Motyl I (2014) Predictive modelling of Lactobacillus casei KN291 survival in fermented soy beverage. J Microbiol 52:169–178
26. Tsangalis D, Wilcox G, Shah NP, Stojanovska L (2005) Bioavailability of isoflavone phytoestrogens in postmenopausal women consuming soya milk fermented with probiotic bifidobacteria. Br J Nutr 93:867–877
27. Li C, Li X, Han H, Cui H, Peng M, Wang G et al (2016) Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized, controlled trials. Medicine 95:e4088
28. Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS (2013) Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab 10:35
29. Tabuchi M, Ozaki M, Tamura A, Yamada N, Ishida T, Hosoda M et al (2003) Antidiabetic effect of Lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 67:1421–1424
30. Lee YH, Magkos F, Mantzoros CS, Kang ES (2011) Effects of leptin and adiponectin on pancreatic beta-cell function. Metab Clin Exp 60:1664–1672
31. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H et al (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361:226–228
32. Kim SW, Park KY, Kim B, Kim E, Hyun CK (2013) Lactobacillus rhamnosus GG improves insulin sensitivity and reduces adiposity in high-fat diet-fed mice through enhancement of adiponectin production. Biochem Biophys Res Commun 431:258–263
33. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y et al (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64:636–643
34. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T et al (2003) Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis–a pilot study. Scand J Rheumatol 32:211–215
35. Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E, Sharif SK, Vaghef-Mehrabany L, Asghari-Jafarabadi M et al (2014) Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int J Rheum Dis 17:519–527
36. Tonucci LB, Olbrich Dos Santos KM, Licursi de Oliveira L, Rocha Ribeiro SM, Duarte Martino HS (2015) Clinical application of probiotics in type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study. Clin Nutr. doi:10.1016/j.clnu.2015.11.011
37. Nikbakht E, Khalesi S, Singh I, Williams LT, West NP, Colson N (2016) Effect of probiotics and synbiotics on blood glucose: a systematic review and meta-analysis of controlled trials. Eur J Clin Nutr. doi:10.1007/s00394-016-1300-3
38. Kasinska MA, Drzewoski J (2015) Effectiveness of probiotics in type 2 diabetes: a meta-analysis. Pol Arch Med Wewn 125:803–813